Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Psychiatry. 2008 May;192(5):338-43. doi: 10.1192/bjp.bp.107.037101.

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.

Author information

  • 1Early Human Experience Unit, Centre for Community Child Health Research, Vancouver, BC, Canada. toberlander@cw.bc.ca

Abstract

BACKGROUND:

Late-gestational serotonin reuptake inhibitor (SRI) exposure has been linked to adverse neonatal outcomes; however, the impact of timing and duration of exposure is unknown.

AIMS:

To determine whether late-gestational exposure to an SRI is associated with increased risk of adverse neonatal outcome relative to early exposure.

METHOD:

Population-based maternal and neonatal health records were linked to prenatal maternal prescription records for an SRI medication (n=3500).

RESULTS:

After controlling for maternal illness and duration of exposure, using propensity score matching, neonatal outcomes did not differ between late and early exposure (P>0.05). After controlling for maternal illness, longer prenatal exposure increased the risks of lower birth weight, respiratory distress and reduced gestational age (P<0.05).

CONCLUSIONS:

Using population health data, length of gestational SRI exposure, rather than timing, increased the risk for neonatal respiratory distress, lower birth weight and reduced gestational age, even when controlling for maternal illness and medication dose. These findings highlight the importance of distinguishing the specific impact of medication exposure from exposure to maternal illness itself.

Comment in

PMID:
18450656
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk